We are looking for:
  • Type 2 Diabetes patients who inject medication
  • NASH patients who inject medication

We are looking to speak to people who have been diagnosed with Type 2 Diabetes or NASH (a form of non-alcoholic fatty liver disease) and currently use an injectable medication, to take part in a research study in March.

The aim of the study is to test the usability and concept of a novel technology (which includes a voice and text chatbot application) that would support an injectable device.

1-1 usability test sessions will last 60 minutes and you will receive a reimbursement of £65.